Lv1
80 积分 2025-11-30 加入
Treatment Options for Refractory Lupus Nephritis
3个月前
已完结
The efficacy of rituximab plus belimumab or telitacicept in refractory lupus nephritis
3个月前
已完结
Efficacy and safety of telitacicept in patients with class III–V lupus nephritis: A real-world retrospective cohort study
3个月前
已完结
Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up
4个月前
已完结
皖公网安备34019202002308
